semaglutide competitors Canada approves first generic version of Ozempic amid rising GLP-1 competition Altimmune (ALT): Odd drug out

, ,

While there are varying perspectives on this issue, in a viewpoint that I was pleased to co-author with Sam Klein and Kevin Hall just published in JAMA, we suggest that the concern regarding physical frailty or sarcopenia with GLP-1-based medications may not be as grounded as some argue

How Semaglutide Works Imagine having a supportive ally on your journey to a healthier weight

Clinics are combining peptides with lab results and patient-reported outcomes to design protocols that target aging, recovery, metabolism, or cognition with greater precision

However, studies support its use for health, brain function, and disease prevention

2015 May Elysia Tjong, Manjari Dimri, Shamim S